Poolbeg Pharma announces expansion of POLB 001 into oncology

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.37
+0.00 (0.00%)
AAPL  349.21
+0.00 (0.00%)
AMD  489.19
+0.00 (0.00%)
BAC  48.57
+0.00 (0.00%)
GOOG  271.02
+0.00 (0.00%)
META  596.22
+0.00 (0.00%)
MSFT  498.30
+0.00 (0.00%)
NVDA  145.98
+0.00 (0.00%)
ORCL  110.57
+0.00 (0.00%)
TSLA  374.41
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.